Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

News Briefs: Approvals For Abbott’s MitraClip, Allergan’s Juvéderm; Diagnostics News

This article was originally published in The Gray Sheet

Executive Summary

FDA approved Abbott’s MitraClip to treat mitral regurgitation and Allergan’s Juvéderm Voluma XC facial filler to temporary correct volume-loss. Hepatitis C testing will be mandatory in New York. More news.

Advertisement

Related Content

US Heart Valve Treatments Market Fueled By New Transcatheter Valves
Medicare Will Cover Hepatitis C Screening For Baby Boomers, High Risk Populations
Trans-Mitral Valve Repair Gains Medicare Coverage-With-Evidence Proposal
CMS Announces FY 2015 New-Tech Add-On Payment Applicants
Myriad Seeks To Diversify While Remaining Aggressive On BRCA Testing Market
TAVR Competitors Put Pressure On Edwards To Deliver On New Growth Drivers
Quest Enters Market For BRCA Gene Testing
Federal Task Force Recommends One-Time HCV Screening For All Baby Boomers
FDA Advisors Vote That Benefits Of Abbott’s MitraClip Outweigh Risks

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT032538

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel